Éva Szekanecz

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.

Csilla András, Andrea Ponyi, Tamás Constantin et al. · PubMed · 2008 · 244 citations

Medicine, Dermatology, Immunology +17

Occurrence of Malignancies in Hungarian Patients with Systemic Lupus Erythematosus

Tünde Tarr, BALÁZS GYORFY, Éva Szekanecz et al. · Annals of the New York Academy of Sciences · 2007 · 60 citations · Full text

Medicine, Immunology, Oncology +13

Increased Production of the Soluble Tumor‐Associated Antigens CA19‐9, CA125, and CA15‐3 in Rheumatoid Arthritis

Éva Szekanecz, Zsuzsa Sándor, Péter Antal‐Szalmás et al. · Annals of the New York Academy of Sciences · 2007 · 55 citations · Full text

Medicine, Immunology, Pathology +11

Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: Associations with organ manifestations, immunolaboratory markers and disease activity indices

Éva Szekanecz, Gabriella Szűcs, Zoltán Szekanecz et al. · Journal of Autoimmunity · 2008 · 55 citations · Full text

Life Sciences, Immunology, Pathobiology +15